AVH News: AVITA Medical Announces FDA Approval of New RECELL® System with Improved Ease of Use - 18th Feb 2022, 8:01am

annb0t

Top 20
AVITA Medical

System enhanced in response to clinician workflow and usability feedback; new system simplifies process

United States product launch planned for Q2 2022

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 17, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that the United S...

>>> Read more: AVITA Medical Announces FDA Approval of New RECELL® System with Improved Ease of Use
 
Top Bottom